Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 04, 2021

SELL
$4.83 - $9.67 $219,373 - $439,201
-45,419 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$6.01 - $8.9 $275,877 - $408,536
-45,903 Reduced 50.26%
45,419 $302,000
Q4 2020

Feb 08, 2021

BUY
$5.91 - $9.11 $539,713 - $831,943
91,322 New
91,322 $540,000

About Vivos Therapeutics, Inc.


  • Ticker VVOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 23,012,100
  • Market Cap $60.3M
  • Description
  • Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dent...
More about VVOS
Track This Portfolio

Track K.J. Harrison & Partners Inc Portfolio

Follow K.J. Harrison & Partners Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of K.J. Harrison & Partners Inc, based on Form 13F filings with the SEC.

News

Stay updated on K.J. Harrison & Partners Inc with notifications on news.